TNFRSF10A and cancer: Examples include recombinant TRAIL and agonistic antibodies targeting DR4 or DR5, which selectively induce apoptosis in cancer cells, and agonistic antibodies and recombinant FasL, which induce apoptosis in Fas‐expressing cancer cells.143, 160